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Abstract A new methodology was developed to access isothiazolone derivatives from simple 
acrylamides by transition metal catalyzed C-H bond functionalization. This Pd-catalyzed 
reaction using an electrophilic SCN source offered an efficient tool to access a panel of 
functionalized isothiazolone derivatives (21 examples, up to 71% yield). 
 
Over the last years, the development of new catalytic systems to tackle unaddressed synthetic 
issues aroused the curiosity of the scientific community to imagine and design new tools. As 
part of them, the direct functionalization of a simple C-H bond appeared as an efficient way to 
accomplish this task and a panel of transition metal catalyzed transformations is now available.1 
With these atom- and step-economical synthetic pathways, unprecedented retrodisconnections 
were achieved, offering original synthetic routes towards the construction of more complex 
molecules.2 However, it is worth mentioning that compared to the tremendous advances made 
for the functionalization of aromatic compounds, the transition metal catalyzed 
functionalization of vinylic derivatives by C-H bond activation is rather limited.3 In this context, 
we turned our attention to the synthesis of isothiazolone derivatives. These underexplored N,S-
heterocycles are of high interest and found applications as antimicrobials, in paint formulation 
as well as in hair care products and shampoos. For instance, N-phenylisothiazolones with 
various substituents at C4 and C5 positions turned out to be good candidates as inhibitors of the 
histone acetyltransferase enzymes.4,5 Usually, N-substituted isothiazolones are prepared by 
different approaches (Scheme 1). Pioneer works from the group of Lewis in 1971, followed by 
several other research groups, relied on the cyclization of N,N’-bis-aryl-3,3’-
dithiodipropionamide derivatives in the presence of chlorine gas, SOCl2 or SO2Cl2 (Scheme 1, 
eq. 1).6 Isothiazolones were also prepared from 3-aroylpropionic amides upon reaction with 
thionyl chloride (Scheme 1, eq. 2).7 An alternative pathway relying on an oxidative addition 
with iodine under basic conditions was depicted by Petraitis and co-workers starting from 3-
aryl-3-mercapto-propenamide derivatives (Scheme 1, eq. 3).8 Finally, complementary 
approaches were developed to access N-substituted-5-aryl/alkyl-substituted-isothiazolones. In 
2009, the group of McDonald developed a Pummerer-like type reaction for the synthesis of N-
aryl-5-aryl-isothiazolone and N-aryl-5-alkyl-isothiazolone compounds (Scheme 1, eq. 4).4 In 
2017, Reddy and co-workers reported a thiocyanation/intramolecular decyanative cyclization 
of ynamides leading to the corresponding N-substituted-5-phenyl-isothiazolones (5 examples, 
Scheme 1, eq. 5).9 Compared to traditional routes, the development of alternative synthetic 
pathways to provide an access to various isothiazolone derivatives with good diversity at the 
C4 position from simple starting materials is appealing.  
 
Scheme 1. Synthesis of isothiazolone derivatives: traditional approaches and present work. 
Inspired by our recent investigations on the functionalization of vinylic C-H bond by transition 
metal catalysis,10 we sought that the reaction of an acrylamide with an electrophilic SCN source 
in the presence of a Pd-catalyst could afford the isothiazolone backbone selectively. Herein, we 
report the first Pd-catalyzed synthesis of 4-substituted and 4,5-disubstituted isothiazolones from 
acrylamide derivatives.  
 
We began our investigation using the acrylamide 1a in presence of the electrophilic SCN source 
I under Pd catalysis at 80 °C under air. The corresponding isothiazolone derivative 2a was 
selectively obtained in a 44% NMR yield.11 Note that no product resulting from the  
thiocyanation reaction was detected.12 First, several Pd-catalysts were tried (Table 1, entries 1-
4) and PdCl2 turned out to be the most efficient one in this transformation. Importantly, in the 
absence of Pd-catalyst, no reaction occurred showcasing with this control experiment its key 
role in the synthesis of isothiazolones (Table 1, entry 5). When the reaction was performed 
under inert atmosphere or in the presence of a catalytic amount of PivOH (25 mol%), similar 
results were obtained (Table 1, entries 6 and 7). When the temperature was lowered to 60 °C, 
2a was isolated in only 51% yield (Table 1, entry 8). On the contrary, an increase of the 
temperature to 100 °C and 120 °C gave similar results, the reaction at 100 °C being the most 
efficient one (Table 1, entries 9 and 10).  Finally, when other solvents were evaluated such as 
1.4-dioxane, toluene and DCE, a shutdown of the reactivity or lower yields were obtained 
(Table 1, entries 11-13).  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Optimization of the reaction conditions a  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Reaction conditions: 1a (0.1 mmol), SCN reagent I (0.3 mmol), catalyst (10 mol%), solvent (0.1 M), T (°C), 16 
h, air. Yields determined by 1H NMR on the crude reaction mixture using 1.1.2.2-tetrachloroethane as an internal 
standard.  b Isolated yields. c Under Ar atmosphere. d Using 25 mol% of PivOH as additive. PivOH = pivalic acid. 
DCE = 1.2-dichloroethane. NR = no reaction.  
With the best reaction conditions in hand, the scope of the transformation was investigated 
under Pd-catalysis. A panel of -aryl acrylamides were functionalized in moderate to good 
yields (Scheme 2). Acrylamides with arenes bearing electron-rich substituents (1a-e) and 
halogens (1g-i) at the para-position were converted into the corresponding N-quinolyl-4-
arylisothiazolones. The presence of the benzyl alcohol (compound 2d) was a key value added 
since not tolerated in the previously reported reaction conditions.9 The substitution pattern on 
the aromatic ring did not have any impact on the reaction outcome as observed with 2b, 2j and 
2m or 2h, 2k and 2n. The reaction was tolerant to various substituents such as halogens and 
entry catalyst  T 
(°C) 
solvent 1H NMR 
yield (%) 
1 Pd(OAc)2  80 DMF 44 
2 PdBr2  80 DMF 45 
3 Pd(CH3CN)2Cl2 80 DMF 55 
4 PdCl2 80 DMF 81, 63
b 
5 None 80 DMF NR 
6c PdCl2 80 DMF 78, 61
b 
7d PdCl2 80 DMF 78, 60
b 
8 PdCl2 60 DMF 62, 51
b 
9 PdCl2 100 DMF 87, 70b 
10  PdCl2 120 DMF 87, 69
b 
11 PdCl2 100 1.4-dioxane NR 
12 PdCl2 100 toluene 55 
13 PdCl2 100 DCE 28 
CF3 group (2g-i, 2k and 2n-o), and no product resulting from a protodehalogenation reaction 
was detected. Note that the reaction was easily scaled up and 2g was synthesized in 65% yield 
on a 1 mmol scale. Heteroaromatic ring was also tolerated as demonstrated with compound 2r, 
although it was obtained in a somehow lower yield (45%). The reaction was not restricted to -
aryl acrylamides and challenging ,-disubstituted acrylamides were also suitable substrates, 
offering an access to fully decorated isothiazolone derivatives. -Phenyl-trans-cinnamide 1s 
and ,-dimethyl acrylamide 1t were engaged in the standard reaction conditions. The 
transformation yielded the corresponding products 2s and 2t in 49% and 51% yields, 
respectively, offering an access to other isothiazolone derivatives and demonstrating the 
synthetic utility of the reaction. Finally, when the amide derived from 8-amino-5-
methoxyquinoline was used as a directing group, the corresponding product 2u was obtained in 
50% and 49% yields (on 0.2 and 0.5 mmol scale, respectively).  However, trans-cinnamide 1v 
was a reluctant substrate, which highlighted the complementary of our approach compared to 
some previous report.9 To gain more insight in the transformation, other directing groups were 
investigated. No reaction was observed with the amide derived from the N-methyl amide 1w, 
highlighting the key role of the NH from the directing group in the reaction. Note that when the 
amide derived from the 2-(aminomethyl)pyridine 3 as well as tertiary amides 4 and 5 were used,  
no reaction occurred. Unfortunately, all attempts to cleave the directing group in the presence 
of CAN to get the free amide failed, and the starting material was fully recovered.  
 
 Scheme 2. Functionalization of acrylamides 1 into the corresponding isothiazolones 2. Reaction conditions: 1 (0.2 
mmol), I (0.6 mmol), PdCl2 (20 mol%), DMF (2 mL), 100 °C, 16 h, air, isolated yields were given. [a] 10 mol% 
of PdCl2 was used. [b] Reaction was performed on a 1 mmol scale using 4 equivalents of I. [c] Reaction was 
performed on a 0.5 mmol scale.  
 
In order to further demonstrate the synthetic utility of the products 2, an additional 
transformation was conducted (Scheme 3). The selective chlorination of the 8-aminoquinoline 
part was realized, bringing functional group diversity on that part of the molecule too. Indeed, 
in the presence of 0.5 equivalent of TCCA, the functionalized isothiazolone 6 was isolated in 
55% yield.  
 Scheme 3. Selective chlorination reaction of the compound 2u 
Based on our previous work regarding the functionalization of olefins according to a C-H bond 
functionalization via Pd-catalysis10c and the fact that the transformation did not occur without 
a Pd-catalyst (Table 1, entry 5), a possible mechanism was suggested (Scheme 4). Subsequent 
to the coordination of the Pd(II)-catalyst with the bidentate directing group, which afforded the 
species A, the corresponding palladacycle (intermediate B) was formed. This process might 
occur via a concerted metalation-deprotonation step. In the presence of the electrophilic SCN 
source I, an oxidative addition reaction with the intermediate B led to a Pd(IV) species C. Then, 
a final reductive elimination along with the protonation of the nitrogen atom of the amide 
regenerated the catalyst and afforded a putative intermediate D, which quickly underwent an 
intramolecular decyanative cyclization to provide the desired isothiazolone 2.9  
  
 
Scheme 4. Plausible catalytic cycle 
Conclusion 
In this study, an original synthesis of N-quinolyl-4-arylisothiazolones and N-quinolyl-4,5-
disubstituted isothiazolones was achieved under an air atmosphere. An array of heterocyclic 
compounds was obtained in moderate to good yields (21 examples, up to 71% yield) using 
simple and neutral reaction conditions. With this approach, not only 4-substituted but also 4,5-
disubstituted isothiazolone derivatives were obtained. A post-functionalization reaction further 
demonstrated the synthetic utility of the depicted approach. We believe that this methodology 
will be of high interest for the scientific community, offering a straightforward access to 
molecules of interest, and demonstrating further how the direct C-H bond functionalization 
might be used to build up more complex molecules.  
  
 
Experimental Section  
All reactions were carried out using oven dried glassware and magnetic stirring under an 
atmosphere of air unless otherwise stated. Reaction temperatures are reported as the 
temperature of the oil bath surrounding the vessel. Analytical thin layer chromatography was 
performed on silica gel aluminium plates with F-254 indicator and visualized by UV light (254 
nm) and/or chemical staining with a KMnO4 solution or a phosphomolybdic acid solution. Flash 
chromatography was performed on Merck silica gel (40-63 mesh) either by standard technique 
or by Biotage Isolera One Flash Purification System (gradient of solvents; PE = petroleum 
ether, Et2O = diethyl ether). 
1H NMR spectra were recorded on a Bruker DXP 300 MHz 
spectrometer at 300.1 MHz, 13C spectra at 75.5 MHz, 19F NMR at 282.4 MHz. Chemical shifts 
(δ) are quoted in parts per million (ppm) relative to residual solvent peak for CDCl3 (δH = 7.26 
ppm; δC = 77.0 ppm; or relative to external CFCl3: δ = 0.0 ppm). Coupling constants (J) are 
quoted in Hz. The following abbreviations were used to show the multiplicities: s: singlet, d: 
doublet, dd: doublet of doublet, m: multiplet. High-Resolution Mass Spectra (HRMS) were 
recorded on Waters LCT Premier. Infrared spectra were recorded on a Perkin Elmer FT-IR 
spectrometer Paragon 100 (ATR); the wave numbers (ν) are quoted in cm-1. Melting points 
were recorded on Kofler bench and are uncorrected. 
PdCl2 was purchased from Sigma-Aldrich Ltd. Dry DMF (N,N-Dimethylformamide, in sealed 
bottle with molecular sieves) was purchased from Acros Organics Ltd. Reagent I was 
synthesized according to the literature procedure.13 Acrylamides 1a,10c 1b,14 1c,10c 1e-1f,10c 
1g,14 1h-1i,10c 1j,14 1k-1l,10c 1m,14 1n,10c 1p,14 1q-1r,10c 1s,15 1t,10c 1u14 were synthesized 
according to the preview reports in the literature. Starting materials 1v,16 3,16 417 and 510b were 
prepared according to literature procedures. 
General Procedures for the Preparation of the Starting Materials 1.  
General procedure for the synthesis of 2-aryl-N-(quinolin-8-yl)acrylamides 1a-1e, 1g-1r. 
Oxalyl chloride (0.94 mL,11 mmol, 1.1 equiv) was slowly added at 0 oC to a solution of the 
corresponding acid (10 mmol, 1.0 equiv) and DMF (3 drops) in freshly distilled CH2Cl2 (15 
mL). After stirring at room temperature for 3 h, the solvent was removed under vacuum and the 
residue was dissolved in freshly distilled CH2Cl2 (50 mL). 8-Aminoquinoline (1.44 g, 10 mmol, 
1 equiv) was added and the reaction was followed by TLC until it was completed. Water (100 
mL) was added. The aqueous layers were extracted with CH2Cl2 (3  150 mL). Then, the 
combined organic layers were dried over MgSO4. Removal of the solvent under vacuum and 
purification of the residue by Biotage afforded the corresponding amide. 
The resulting amide derived from 8-aminoquinoline (5 mmol, 1.0 equiv), (CHO)n (0.44 g, 15 
mmol, 3.0 equiv), (nBu)4NHSO4 (0.17 g, 0.5 mmol, 0.1 equiv) and K2CO3 (1.04 g, 7.5 mmol, 
1.5 equiv) were added in toluene (80 mL) and stirred at 80 oC. The reaction was followed by 
TLC until it was completed. Water (100 mL) was added. The aqueous layers were extracted 
with Et2O (3  150 mL). Then, the combined organic layers were dried over Na2SO4. Removal 
of the solvent under vacuum and purification of the residue by Biotage afforded the desired 2-
aryl-N-(quinolin-8-yl)acrylamides 1. 
General procedure for the synthesis of 2-Phenyl-N-(quinolin-8-yl)acrylamide 1f, 1s and 1t. 
Oxalyl chloride (0.47 mL, 5.5 mmol, 1.1 equiv) was slowly added at 0 oC to a solution of the 
corresponding acid (5 mmol, 1.0 equiv) and DMF (3 drops) in freshly distilled CH2Cl2 (40 mL). 
After stirring at room temperature for 3 h, the solvent was removed under vacuum and the 
residue was dissolved in freshly distilled CH2Cl2 (50 mL). 8-Aminoquinoline (0.72 g, 5 mmol, 
1 equiv) was added and the reaction was followed by TLC until it was completed. Water (100 
mL) was added. The aqueous layers were extracted with Et2O (3  150 mL). Then, the combined 
organic layers were dried over Na2SO4. Removal of the solvent under vacuum and purification 
of the residue by Biotage afforded the desired product 1. 
N-(5-Methoxyquinolin-8-yl)-2-phenylacrylamide 1u was prepared by using a similar procedure 
as the one depicted above for 1f by replacing the 8-aminoquinoline with the 5-methoxy-8-
aminoquinoline. 
General procedure for the synthesis of N-methyl-N-(quinolin-8-yl)-2-(o-tolyl)acrylamide 1w.18 
To a suspension of sodium hydride (60%) (80 mg, 2 mmol, 2.0 equiv) in dry DMF (5 mL), was 
added a solution of 1m (288 mg, 1 mmol, 1 equiv) in dry DMF (10 mL) at 0 oC. Then, the 
reaction mixture was warmed to room temperature and stirred for 0.5 h. Then, methyl iodide 
(81 µL, 1.3 mmol, 1.3 equiv) was added dropwise and the reaction was stirred at 25 oC for 3 h. 
The reaction was diluted with CH2Cl2 (30 mL) and the organic layer was washed with water (3 
x 15 mL), dried over Na2SO4. Removal of the solvent under vacuum and purification of the 
residue by Biotage afforded the desired product 1w. 
Purification and Characterization of the Starting Materials 1.  
2-(4-(Hydroxymethyl)phenyl)-N-(quinolin-8-yl)-acrylamide (1d): Purification by silica gel 
column chromatography (Biotage system 25 g, height 80 mm, width 30 mm, eluent: petroleum 
ether/diethyl ether, from 100/0 to 50/50). Yield: 45% (684 mg). Rf (petroleum ether/diethyl 
ether, 50/50): 0.41. White solid; m.p.: 96-97 oC. 1H NMR (300.1 MHz, CDCl3): δ 10.25 (brs, 
1H), 8.87 (d, J = 7.2 Hz, 1H), 8.72-8.59 (m, 1H), 8.11 (d, J = 8.1 Hz, 1H), 7.63-7.31 (m, 7H), 
6.27 (s, 1H), 5.82 (s, 1H), 4.74 (s, 2H). Note that the proton of OH was not visible. 13C{1H} 
NMR (75.5 MHz, CDCl3): δ 165.9, 148.3, 145.6, 141.4, 138.6, 136.2, 135.9, 134.4, 128.4, 
127.9, 127.3, 127.1, 121.9, 121.9, 121.5, 116.7, 64.9. IR (neat, cm-1) : 3455, 3350, 2855, 1670, 
1522, 1485, 1426, 1389, 1166, 1031, 826, 667. HRMS (ESI+): calcd for C19H17N2O2 m/z 
305.1290 [M+H]+, found 305.1277 (-4.3 ppm). 
2-(2-Bromophenyl)-N-(quinolin-8-yl)-acrylamide (1o): Purification by silica gel column 
chromatography (Biotage system 25 g, height 80 mm, width 30 mm, eluent: petroleum 
ether/diethyl ether, from 100/0 to 75/25). Yield: 66% (1.18 g). Rf (petroleum ether/diethyl ether, 
50/50): 0.52. Red solid; m.p.: 123-124 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.90 (brs, 1H), 8.69 
(dd, J = 7.5 Hz, 1.2 Hz, 1H), 8.37-8.32 (m, 1H), 7.90-7.82 (m, 1H), 7.49 (d, J = 7.8, 1H), 7.36-
7.23 (m, 4H), 7.17-7.09 (m, 2H), 6.44 (d, J = 1.2 Hz, 1H), 5.55 (d, J = 0.9 Hz, 1H). 13C{1H} 
NMR (75.5 MHz, CDCl3): δ 163.7, 148.2, 145.3, 138.6, 138.3, 136.1, 134.4, 133.0, 131.7, 
130.1, 127.8, 127.8, 127.3, 125.7, 123.8, 121.7, 121.5, 116.4. IR (neat, cm-1) : 3328, 1675, 
1523, 1484, 1385, 1325, 1027, 790, 762, 682. HRMS (ESI+): calcd for C18H14BrN2O m/z 
353.0290 [M+H]+, found 353.0296 (1.7 ppm). 
N-Methyl-N-(quinolin-8-yl)-2-(o-tolyl)-acrylamide (1w): Purification by silica gel column 
chromatography (Biotage system 25 g, height 80 mm, width 30 mm, eluent: petroleum 
ether/diethyl ether, from 100/0 to 75/25). Yield: 70% (211 mg). Rf (petroleum ether/diethyl 
ether, 50/50): 0.59. Yellow oil. 1H NMR (300.1 MHz, CDCl3): δ 8.87-8.73 (m, 1H), 7.99 (dd, J 
= 8.4 Hz, 1.5 Hz, 1H), 7.67-7.53 (m, 1H), 7.38-7.16 (m, 3H), 6.66-6.50 (m, 2H), 6.57-6.45 (m, 
1H), 6.33-6.18 (m, 1H), 6.07 (s, 1H), 5.22 (s, 1H), 3.54 (s, 3H), 2.11 (s, 3H). 13C{1H} NMR 
(75.5 MHz, CDCl3): δ 171.2, 149.7, 146.9, 143.7, 140.4, 136.8, 135.4, 135.1, 129.0, 128.6, 
128.6, 128.1, 127.7, 126.3, 125.7, 124.6, 123.5, 121.2, 37.8, 19.7. IR (neat, cm-1) : 2965, 2932, 
1639, 1613, 1391, 1354, 1281, 1197, 1086, 945, 834, 796. HRMS (ESI+): calcd for C20H19N2O 
m/z 303.1497 [M+H]+, found 303.1501 (1.3 ppm). 
General Procedure for the Synthesis of Derivatives 2.  
A dried tube was loaded with PdCl2 (7.1 mg, 0.04 mmol, 20 mol%), reagent I (122.4 mg, 0.6 
mmol, 3.0 equiv) and amide 1 (0.2 mmol, 1.0 equiv). Then DMF (2 mL) was injected. The tube 
was sealed with a cap and the suspension was stirred at 100 oC (oil bath) for 16 h. After cooling 
down, the reaction was diluted with Et2O (30 mL). Then, the organic layers were washed by 
water (2 x 10 mL), by an aqueous saturated NaHCO3 solution (10 mL), dried over Na2SO4, and 
solvents were removed under vacuum. The residue was directly purified by silica gel column 
chromatography to give the desired product 2. Note that for some compounds (see Scheme 2 in 
the manuscript), 10 mol% PdCl2 were used (3.5 mg, 0.02 mmol). 
 
Purification and Characterization of the Isothiazolones 2.  
2-(Quinolin-8-yl)-4-(4-(tert-butyl)phenyl)-isothiazol-3(2H)-one (2a): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 70% (50 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.39. White 
solid; m.p.: 244-245 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.00-8.93 (m, 1H), 8.43 (s, 1H), 8.23 
(d, J = 7.5 Hz, 1H), 8.05 (d, J = 7.2 Hz, 1H), 7.94-7.84 (m, 3H), 7.68-7.59 (m, 1H), 7.51-7.42 
(m, 3H), 1.35 (s, 9H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.3, 151.0, 150.6, 143.9, 136.4, 
135.2, 134.2, 133.7, 129.8, 129.6, 129.3, 128.9, 126.5, 126.3, 125.5, 123.7, 123.5, 121.8, 34.6, 
31.3. IR (neat, cm-1) : 2960, 1623, 1609, 1500, 1471, 1315, 1267, 831, 786. HRMS (ESI+): 
calcd for C22H21N2OS m/z 361.1375 [M+H]
+, found 361.1388 (3.6 ppm). 
2-(Quinolin-8-yl)-4-(4-methylphenyl)-isothiazol-3(2H)-one (2b): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 59% (38 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.37. White 
solid; m.p.: 206-207 oC. 1H NMR (300.1 MHz, CDCl3): δ 8.96 (dd, J = 4.2 Hz, 1.8 Hz, 1H), 
8.42 (s, 1H), 8.22 (dd, J = 8.4 Hz, 1.8 Hz, 1H), 8.04 (dd, J = 7.2 Hz, 1.2 Hz, 1H), 7.93-7.83 (m, 
3H), 7.67-7.60 (m, 1H), 7.50-7.41 (m, 1H), 7.25-7.20 (m, 2H), 2.38 (s, 3H). 13C{1H} NMR 
(75.5 MHz, CDCl3): δ 167.2, 150.6, 143.9, 137.8, 136.4, 135.0, 133.7, 129.8, 129.6, 129.3, 
129.2, 128.9, 126.6, 126.2, 123.6, 121.8, 21.3. IR (neat, cm-1) : 1647, 1495, 1387, 1267, 1186, 
828, 793, 615, 529. HRMS (ESI+): calcd for C19H15N2OS m/z 319.0905 [M+H]
+, found 
319.0902 (-0.9 ppm). 
2-(Quinolin-8-yl)-4-(4-methoxyphenyl)-isothiazol-3(2H)-one (2c): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 52% (35 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.30. Yellow 
solid; m.p.: 142-143 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.01-8.92 (m, 1H), 8.37 (s, 1H), 8.22 
(d, J = 8.1 Hz, 1H), 8.02 (d, J = 7.5 Hz, 1H), 7.98-7.84 (m, 3H), 7.69-7.58 (m, 1H), 7.50-7.40 
(m, 1H), 6.96 (d, J = 8.7 Hz, 2H). 3.83 (s, 3H).
 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.2, 
159.4, 150.7, 144.0, 136.3, 134.0, 133.8, 129.7, 129.3, 128.9, 128.0, 126.2, 125.4, 123.3, 121.8, 
113.9, 55.3. IR (neat, cm-1) : 2932, 2839, 1642, 1544, 1498, 1387, 1274, 1252, 1178, 1030, 
822, 795, 759, 577. HRMS (ESI+): calcd for C19H15N2O2S m/z 335.0854 [M+H]
+, found 
335.0866 (3.6 ppm). 
2-(Quinolin-8-yl)-4-(4-(hydroxymethyl)phenyl)-isothiazol-3(2H)-one (2d): Purification by 
silica gel column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, 
from 100/0 to 75/25 to 50/50). Yield: 41% (27 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.22. 
Yellow solid; m.p.: 176-177 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.01-8.93 (m, 1H), 8.51 (s, 
1H), 8.25 (dd, J = 8.1 Hz, 1.8 Hz, 1H), 8.09-7.89 (m, 4H), 7.72-7.59 (m, 1H), 7.53-7.40 (m, 
3H), 4.62 (s, 2H). Note that, the proton of OH is not visible. 13C{1H} NMR (75.5 MHz, CDCl3): 
δ 167.0, 150.7, 143.9, 137.0, 136.4, 136.2, 133.6, 132.7, 129.6, 129.3, 129.0, 128.8, 127.0, 
126.2, 123.0, 121.9, 46.1. IR (neat, cm-1) : 3053, 2921, 2850, 1628, 1599, 1497, 1471, 1320, 
1259, 1203, 1132, 822, 783, 662. HRMS (ESI+): calcd for C19H15N2O2S m/z 335.0854 [M+H]
+, 
found 335.0864 (3.0 ppm). 
2-(Quinolin-8-yl)-4-([1,1'-biphenyl]-4-yl)-isothiazol-3(2H)-one (2e): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 50% (38 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.33. Yellow 
solid; m.p.: 166-167 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.02-8.93 (m, 1H), 8.53 (s, 1H), 8.24 
(dd, J = 8.4 Hz, 1.5Hz, 1H), 8.11-8.03 (m, 3H), 7.92 (d, J = 7.2 Hz, 1H), 7.71-7.58 (m, 5H), 
7.50-7.32 (m, 4H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.1, 150.7, 143.9, 140.7, 140.6, 
136.4, 135.7, 133.6, 131.6, 129.6, 129.3, 129.0, 128.7, 127.3, 127.2, 127.0, 126.2, 123.5, 123.2, 
121.9. IR (neat, cm-1) : 2921, 1732, 1637, 1495, 1385, 1260, 1081, 823, 794, 765, 606. HRMS 
(ESI+): calcd for C24H17N2OS m/z 381.1062 [M+H]
+, found 381.1055 (-1.8 ppm). 
2-(Quinolin-8-yl)-4-phenyl-isothiazol-3(2H)-one (2f): Purification by silica gel column 
chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 100/0 to 
75/25 to 50/50). Yield: 62% (37 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.42. Yellow solid; 
m.p.: 222-223 oC. 1H NMR (300.1 MHz, CDCl3): δ 8.98-8.91 (m, 1H), 8.47 (s, 1H), 8.20 (dd, 
J = 7.2 Hz, 1.2 Hz, 1H), 8.06-7.85 (m, 4H), 7.66-7.58 (m, 1H), 7.48-7.30 (m, 4H). 13C{1H} 
NMR (75.5 MHz, CDCl3): δ 166.6, 150.8, 150.5, 147.5, 143.8, 136.9, 136.5, 136.5, 133.1, 
129.6, 129.4, 127.6, 126.2, 124.1, 122.0, 119.4. IR (neat, cm-1) : 3092, 1646, 1596, 1501, 
1458, 1316, 1273, 1104, 823, 784, 613, 477. HRMS (ESI+): calcd for C18H13N2OS m/z 305.0749 
[M+H]+, found 305.0756 (2.3 ppm). 
2-(Quinolin-8-yl)-4-(4-fluorophenyl)-isothiazol-3(2H)-one (2g): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 66/34). Yield: 71% (46 mg), 65% (209 mg) on 1 mmol scale. Rf (n-
pentane/ethyl acetate, 50/50): 0.43. Yellow solid; m.p.: 209-210 oC. 1H NMR (300.1 MHz, 
CDCl3): δ 9.00-8.93 (m, 1H), 8.44 (s, 1H), 8.24 (d, J = 8.1 Hz, 1H), 8.03 (d, J = 7.2 Hz, 1H), 
7.99-7.89 (m, 3H), 7.70-7.61 (m, 1H), 7.52-7.43 (m, 1H), 7.15-7.05 (m, 2H). 19 F NMR (282.4 
MHz, CDCl3): δ -113.9 to -114.2 (m, 1F). 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.0, 162.5 
(d, J = 247.6 Hz), 150.7, 144.0, 136.4, 135.5, 133.6, 129.6, 129.3, 129.1, 128.7 (d, J = 3.0 Hz), 
128.5 (d, J = 8.3 Hz), 126.2, 122.6, 121.9, 115.4 (d, J = 21.1 Hz). IR (neat, cm-1) : 3064, 1635, 
1551, 1499, 1389, 1215, 1166, 810, 785, 561, 530. HRMS (ESI+): calcd for C18H12FN2OS m/z 
323.0654 [M+H]+, found 323.0650 (-1.2 ppm). 
2-(Quinolin-8-yl)-4-(4-chlorophenyl)-isothiazol-3(2H)-one (2h): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 60% (41 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.40. Yellow 
solid; m.p.: 208-209 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.00-8.93 (m, 1H), 8.49 (s, 1H), 8.24 
(d, J = 8.1 Hz, 1H), 8.11 (d, J = 7.5 Hz, 1H), 7.98-7.89 (m, 3H), 7.70-7.61 (m, 1H), 7.52-7.45 
(m, 1H), 7.42-7.36 (m, 2H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 166.9, 150.7, 143.9, 136.4, 
136.0, 133.8, 133.5, 131.0, 129.6, 129.3, 129.1, 128.7, 127.9, 126.2, 122.4, 121.9. IR (neat, cm-
1) : 3048, 1721, 1632, 1538, 1470, 1388, 1317, 1279, 1090, 1012, 811, 786, 611, 523, 474. 
HRMS (ESI+): calcd for C18H12ClN2OS m/z 339.0359 [M+H]
+, found 339.0360 (0.3 ppm). 
2-(Quinolin-8-yl)-4-(4-iodophenyl)-isothiazol-3(2H)-one (2i): Purification by silica gel column 
chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 100/0 to 
75/25 to 50/50). Yield: 45% (39 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.37. Yellow solid; 
m.p.: 215-216 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.00-8.92 (m, 1H), 8.50 (s, 1H), 8.23 (dd, 
J = 8.4 Hz, 1.5 Hz, 1H), 8.02 (dd, J = 7.2 Hz, 0.9 Hz, 1H), 7.92 (d, J = 8.1 Hz, 1 H), 7.78-7.62 
(m, 5H), 7.51-7.43 (m, 1H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 166.8, 150.7, 143.9, 137.6, 
136.4, 136.1, 133.4, 132.0, 129.6, 129.3, 129.1, 128.3, 126.2, 122.4, 121.9, 93.7. IR (neat, cm-
1) : 3044, 2162, 1630, 1532, 1470, 1388, 1321, 1198, 1004, 827, 799, 609, 523. HRMS (ESI+): 
calcd for C18H12IN2OS m/z 430.9715 [M+H]
+, found 430.9708 (-1.6 ppm). 
2-(Quinolin-8-yl)-4-(3-methylphenyl)-isothiazol-3(2H)-one (2j): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 61% (39 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.36. Yellow 
solid; m.p.: 180-181 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.00-8.92 (m, 1H), 8.46 (s, 1H), 8.22 
(dd, J = 8.4 Hz, 1.2 Hz, 1H), 8.03 (d, J = 7.5 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 7.83 (s, 1H), 
7.72 (d, J = 7.8 Hz, 1H), 7.67-7.58 (m, 1H), 7.50-7.41 (m, 1H), 7.36-7.27 (m, 1H), 7.20-7.12 
(m, 1H), 2.39 (s, 3H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.1, 150.6, 143.9, 138.0, 136.3, 
135.8, 133.7, 132.5, 129.5, 129.2, 128.9, 128.7, 128.3, 127.3, 126.1, 123.8, 123.6, 121.8, 21.5. 
IR (neat, cm-1) : 3048, 1644, 1496, 1380, 1324, 1278, 1149, 830, 787, 693, 608. HRMS (ESI+): 
calcd for C19H15N2OS m/z 319.0905 [M+H]
+, found 319.0913 (2.5 ppm). 
2-(Quinolin-8-yl)-4-(3-chlorophenyl)-isothiazol-3(2H)-one (2k): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 51% (35 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.39. Yellow 
solid; m.p.: 150-151 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.00-8.91 (m, 1H), 8.51 (s, 1H), 8.23 
(d, J = 8.1 Hz, 1H), 8.06-7.98 (m, 2H), 7.94-7.82 (m, 2H), 7.70-7.59 (m, 1H), 7.50-7.43 (m, 
1H), 7.38-7.28 (m, 2H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 166.8, 150.7, 143.9, 136.7, 136.4, 
134.5, 134.2, 133.4, 129.7, 129.6, 129.3, 129.1, 128.0, 126.6, 126.2, 124.7, 122.1, 121.9. IR 
(neat, cm-1) : 3064, 1727, 1651, 1596, 1502, 1472, 1319, 1280, 1149, 825, 778, 608. HRMS 
(ESI+): calcd for C18H12ClN2OS m/z 339.0359 [M+H]
+, found 339.0364 (1.5 ppm). 
2-(Quinolin-8-yl)-4-(3-(trifluoromethyl)phenyl)-isothiazol-3(2H)-one (2l): Purification by 
silica gel column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, 
from 100/0 to 75/25 to 50/50). Yield: 65% (48 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.34. 
Yellow solid; m.p.: 140-141 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.01-8.89 (m, 1H), 8.58 (s, 
1H), 8.33-8.10 (m, 3H), 8.06-7.98 (m, 1H), 7.91 (d, J = 8.1 Hz, 1H), 7.69-7.43 (m, 4H). 19F 
NMR (282.4 MHz, CDCl3): δ -63.1 (s, 3F). 13C{1H} NMR (75.5 MHz, CDCl3): δ 166.8, 150.7, 
143.9, 137.1, 136.4, 133.3, 133.2, 130.1 (q, J = 32.5 Hz), 129.7 (q, J = 1.1 Hz), 129.6, 129.3, 
129.2, 128.9, 126.1, 124.4 (q, J = 3.8 Hz), 124.1 (q, J = 277.1 Hz), 123.3 (q, J = 3.8 Hz), 121.9. 
IR (neat, cm-1) : 3053, 1651, 1503, 1473, 1391, 1331, 1262, 1114, 1072, 826, 789. HRMS 
(ESI+): calcd for C19H12F3N2OS m/z 373.0622 [M+H]
+, found 373.0612 (-2.7 ppm). 
2-(Quinolin-8-yl)-4-(2-methylphenyl)-isothiazol-3(2H)-one (2m): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 68% (43 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.36. White 
solid; m.p.: 156-157 oC. 1H NMR (300.1 MHz, CDCl3): δ 8.98-8.93 (m, 1H), 8.27-8.16 (m, 
2H), 8.09 (d, J = 7.5 Hz, 1H), 7.85 (d, J = 8.1 Hz, 1H), 7.66-7.57 (m, 1H), 7.49-7.40 (m, 2H), 
7.30-7.19 (m, 3H), 2.44 (s, 3H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.2, 150.3, 143.6, 
138.2, 137.3, 136.3, 133.9, 132.6, 130.4, 130.2, 129.2, 129.0, 128.5, 128.3, 126.2, 125.8, 125.7, 
121.7, 20.3. IR (neat, cm-1) : 3064, 2927, 1651, 1592, 1501, 1472, 1312, 1130, 829, 744, 606, 
452. HRMS (ESI+): calcd for C19H15N2OS m/z 319.0905 [M+H]
+, found 319.0901 (-1.3 ppm). 
2-(Quinolin-8-yl)-4-(2-chlorophenyl)-isothiazol-3(2H)-one (2n): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 62% (42 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.41. Yellow 
solid; m.p.: 84-85 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.01-8.94 (m, 1H), 8.67 (s, 1H), 8.22 
(dd, J = 8.1 Hz, 1.5 Hz, 1H), 8.11 (dd, J = 7.5 Hz, 1.2 Hz, 1H), 7.88 (dd, J = 8.1 Hz, 0.9 Hz, 
1H), 7.81 (dd, J = 7.5 Hz, 2.1 Hz, 1H), 7.67-7.58 (m, 1H), 7.52-7.44 (m, 2H), 7.36-7.24 (m, 
2H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 167.1, 150.4, 143.5, 140.5, 136.4, 133.6, 132.9, 
131.3, 131.2, 130.0, 129.2, 129.1, 129.1, 128.6, 126.7, 126.2, 121.8, 121.2. IR (neat, cm-1) : 
3053, 2233, 1628, 1498, 1468, 1387, 1320, 907, 823, 723, 564. HRMS (ESI+): calcd for 
C18H12ClN2OS m/z 339.0359 [M+H]
+, found 339.0374 (4.4 ppm). 
2-(Quinolin-8-yl)-4-(2-bromophenyl)-isothiazol-3(2H)-one (2o): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 65% (50 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.38. Yellow 
solid. m.p.: 64-65 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.03-8.93 (m, 1H), 8.62 (s, 1H), 8.22 
(dd, J = 8.4 Hz, 1.5 Hz, 1H), 8.12 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 7.87 (d, J = 8.4 Hz, 1H), 7.74-
7.59 (m, 3H), 7.51-7.42 (m, 1H), 7.41-7.32 (m, 1H), 7.24-7.15 (m, 1H). 13C{1H} NMR (75.5 
MHz, CDCl3): δ 167.0, 150.3, 143.5, 140.5, 136.4, 133.6, 133.3, 133.2, 131.6, 129.4, 129.2, 
129.0, 128.5, 127.3, 126.2, 123.2, 123.1, 121.8. IR (neat, cm-1) : 2927, 2233, 1721, 1629, 
1595, 1498, 1469, 1320, 1283, 823, 723, 607. HRMS (ESI+): calcd for C18H12BrN2OS m/z 
384.9833 [M+H]+, found 384.9840 (1.8 ppm). 
2-(Quinolin-8-yl)-4-(3,4-dimethoxyphenyl)-isothiazol-3(2H)-one (2p): Purification by silica 
gel column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 50/50 to 34/66). Yield: 47% (34 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.15. Yellow 
solid; m.p.: 209-210 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.02-8.91 (m, 1H), 8.42 (s, 1H), 8.25 
(d, J = 8.4 Hz, 1H), 8.02 (d, J = 7.5 Hz, 1H), 7.93 (d, J = 8.1 Hz, 1H), 7.82-7.75 (m, 1H), 7.71-
7.61 (m, 1H), 7.54-7.39 (m, 2H), 6.93 (d, J = 8.4 Hz, 1H), 3.92 (s, 6H).
 13C{1H} NMR (75.5 
MHz, CDCl3): δ 167.3, 150.8, 148.9, 148.8, 144.1, 136.4, 134.2, 133.7, 129.9, 129.4, 129.2, 
126.3, 125.7, 123.1, 121.9, 119.2, 111.1, 109.9, 55.9, 55.9. IR (neat, cm-1) : 2960, 2916, 1643, 
1497, 1330, 1244, 1135, 1022, 795, 593. HRMS (ESI+): calcd for C20H17N2O3S m/z 365.0960 
[M+H]+, found 365.0964 (1.1 ppm). 
2-(Quinolin-8-yl)-4-(benzo[d][1,3]dioxol-5-yl)-isothiazol-3(2H)-one (2q):  Purification by 
silica gel column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, 
from 100/0 to 75/25 to 50/50). Yield: 48% (34 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.28. 
Yellow solid; m.p.: 234-235 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.03-8.91 (m, 1H), 8.36 (s, 
1H), 8.24 (d, J = 8.1 Hz, 1H), 8.02 (d, J = 7.2 Hz, 1H), 7.91 (d, J = 8.1 Hz, 1H), 7.73-7.60 (m, 
1H), 7.56-7.41 (m, 3H), 6.87 (d, J = 8.4 Hz, 1H), 5.98 (s, 2H).
 13C{1H} NMR (75.5 MHz, 
CDCl3): δ 167.0, 150.7, 147.8, 147.4, 144.0, 136.4, 134.5, 133.7, 129.6, 129.3, 129.0, 126.8, 
126.2, 123.2, 121.9, 120.6, 108.4, 107.3, 101.1. IR (neat, cm-1) : 3097, 2921, 1628, 1490, 
1388, 1323, 1257, 1108, 1032, 932, 821, 801, 768, 615. HRMS (ESI+): calcd for C19H13N2O3S 
m/z 349.0647 [M+H]+, found 349.0651 (1.1 ppm). 
2-(Quinolin-8-yl)-4-(6-chloropyridin-3-yl)-isothiazol-3(2H)-one (2r): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 66/34 to 50/50). Yield: 45% (31 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.22. Yellow 
solid; m.p.: 151-152 oC. 1H NMR (300.1 MHz, CDCl3): δ 8.99-8.92 (m, 1H), 8.91-8.83 (m, 
1H), 8.61 (s, 1H), 8.40 (dd, J = 8.1 Hz, 2.4 Hz, 1H), 8.25 (dd, J = 8.4 Hz, 1.5 Hz, 1H), 8.02 (d, 
J = 7.5 Hz, 1H), 7.94 (d, J = 8.1 Hz, 1H), 7.70-7.61 (m, 1H), 7.54-7.45 (m, 1H), 7.38 (d, J = 
8.4 Hz, 1H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 166.6, 150.8, 150.4, 147.5, 143.8, 136.9, 
136.5, 136.4, 133.1, 129.6, 129.4, 129.3, 127.6, 126.2, 124.0, 122.0, 119.3. IR (neat, cm-1) : 
3053, 1651, 1500, 1470, 1318, 1145, 1276, 824, 762, 694, 605. HRMS (ESI+): calcd for 
C17H11ClN3OS m/z 340.0311 [M+H]
+, found 340.0308 (-0.9 ppm). 
2-(Quinolin-8-yl)-4,5-diphenyl-isothiazol-3(2H)-one (2s): Purification by silica gel column 
chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 100/0 to 
66/34 to 50/50). Yield: 49% (38 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.31. Yellow solid; 
m.p.: 229-230 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.05-8.96 (m, 1H), 8.25 (d, J = 8.4 Hz, 1H), 
8.19 (d, J = 7.5 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 7.69-7.61 (m, 1H), 7.52-7.45 (m, 3H), 7.40-
7.27 (m, 8H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 168.0, 152.9, 150.3, 143.6, 136.5, 133.9, 
132.4, 131.0, 130.1, 130.0, 129.3, 129.0, 128.9, 128.5, 128.3, 128.2, 127.7, 126.3, 121.8, 121.6. 
IR (neat, cm-1) : 2921, 1652, 1502, 823, 779. 695, 601, 508. HRMS (ESI+): calcd for 
C24H17N2OS m/z 381.1062 [M+H]
+, found 381.1078 (4.2 ppm). 
2-(Quinolin-8-yl)-4,5-dimethyl-isothiazol-3(2H)-one (2t): Purification by silica gel column 
chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 100/0 to 
66/34 to 75/25). Yield: 51% (26 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.12. Yellow solid; 
m.p.: 200-201 oC. 1H NMR (300.1 MHz, CDCl3): δ 9.02-8.92 (m, 1H), 8.22 (dd, J = 8.4 Hz, 
1.5 Hz, 1H), 7.97 (d, J = 7.2 Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.67-7.56 (m, 1H), 7.49-7.40 
(m, 1H), 2.40 (s, 3H), 2.07 (s, 3H). 13C{1H} NMR (75.5 MHz, CDCl3): δ 169.4, 150.4, 147.4, 
144.1, 136.3, 134.1, 129.3, 129.3, 128.4, 126.3, 121.7, 118.6, 13.1, 10.7. IR (neat, cm-1) : 
2916, 1634, 1496, 1328, 829, 793. 695, 624, 509. HRMS (ESI+): calcd for C14H13N2OS m/z 
257.0749 [M+H]+, found 257.0745 (-1.6 ppm). 
2-(5-Methoxyquinolin-8-yl)-4-phenyl-isothiazol-3(2H)-one (2u): Purification by silica gel 
column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25 to 50/50). Yield: 50% (33 mg), 49% (82 mg) on 0.5 mmol scale. Rf (n-
pentane/ethyl acetate, 50/50): 0.40. Yellow solid; m.p.: 156-157 oC. 1H NMR (300.1 MHz, 
CDCl3): δ 9.03-8.84 (m, 1H), 8.61 (d, J = 8.4 Hz, 1H), 8.45 (s, 1H), 7.97 (d, J = 7.2 Hz, 2H), 
7.87 (d, J = 7.8 Hz, 1H), 7.50-7.30 (m, 4H), 6.92 (d, J = 8.4 Hz, 1H), 4.03 (s, 3H).
 13C{1H} 
NMR (75.5 MHz, CDCl3): δ 167.2, 155.9, 151.1, 144.9, 135.4, 132.7, 131.2, 130.5, 128.5, 
127.9, 126.7, 125.9, 123.7, 121.6, 120.9, 103.7, 56.0. IR (neat, cm-1) : 3070, 1728, 1656, 1590, 
1477, 1369, 1276, 1153, 1091, 811, 770, 695, 610. HRMS (ESI+): calcd for C19H15N2O2S m/z 
335.0854 [M+H]+, found 335.0864 (3.0 ppm). 
Post-functionalization reaction of the product 2u.18 In a dried tube was added 2u (33.4 mg, 
0.1 mmol) and TCCA (23.2 mg, 0.1 mmol, 1 equiv) under air. Then acetonitrile (1 mL) was 
injected. The tube was sealed with a cap and the suspension was stirred at room temperature for 
6 h. The reaction was diluted with acetonitrile (15 mL). Then, the organic layers were washed 
by water (2 x 10 mL), by an aqueous saturated NaHCO3 solution (10 mL), dried over Na2SO4, 
and solvents were removed under vacuum. The residue was directly purified by silica gel 
column chromatography to afford the desired product 6 (20 mg, 55%). 
N-(7-Chloro-5-methoxyquinolin-8-yl)-4-phenyl-isothiazol-3(2H)-one (6): Purification by silica 
gel column chromatography (height 18 cm, width 1.5 cm, eluent: n-pentane/ethyl acetate, from 
100/0 to 75/25). Yield: 55% (20 mg). Rf (n-pentane/ethyl acetate, 50/50): 0.65. Yellow solid; 
m.p.: 166-167 oC. 1H NMR (300.1 MHz, CDCl3): δ 8.99-8.89 (m, 1H), 8.56-8.44 (m, 2 H), 8.08 
(s, 1H), 7.94 (d, J = 7.5 Hz, 2H), 7.60-7.32 (m, 4H), 4.08 (s, 3H). 13C{1H} NMR (75.5 MHz, 
CDCl3): δ 167.1, 152.1, 150.7, 143.5, 136.0, 132.4, 131.3, 131.1, 130.3, 128.5, 128.1, 126.7, 
124.9, 123.6, 123.1, 122.3, 61.9. IR (neat, cm-1) : 3064, 3031, 2949, 1645, 1585, 1469, 1367, 
1257, 1168, 1080, 978, 876, 769, 690, 578. HRMS (ESI+): calcd for C19H14ClN2O2S m/z 
369.0465 [M+H]+, found 369.0461 (-1.1 ppm). 
Supporting Information: spectral data for all new compounds found in the SI. 
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